Page last updated: 2024-11-01

nilutamide and Urethral Obstruction

nilutamide has been researched along with Urethral Obstruction in 1 studies

Urethral Obstruction: Partial or complete blockage in any part of the URETHRA that can lead to difficulty or inability to empty the URINARY BLADDER. It is characterized by an enlarged, often damaged, bladder with frequent urges to void.

Research Excerpts

ExcerptRelevanceReference
"Patients with advanced prostate cancer have a beneficial effect from maximal androgen blockade in terms of the subjective and objective delay of progression and median duration of survival, although side effects do occur more often in the combination treatment than in testicular suppression alone."2.68Improved subjective responses to orchiectomy plus nilutamide (anandron) in comparison to orchiectomy plus placebo in metastatic prostate cancer. International Anandron Study Group. ( Debruyne, FM; Dijkman, GA; Fernandez del Moral, P; Janknegt, RA, 1995)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dijkman, GA1
Fernandez del Moral, P1
Debruyne, FM1
Janknegt, RA1

Trials

1 trial available for nilutamide and Urethral Obstruction

ArticleYear
Improved subjective responses to orchiectomy plus nilutamide (anandron) in comparison to orchiectomy plus placebo in metastatic prostate cancer. International Anandron Study Group.
    European urology, 1995, Volume: 27, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Combined Modality Therapy; Disease Progression; Double-Blind Method;

1995